放射治療市場、機會、成長動力、產業趨勢分析與預測，2024-2032

2023 年全球放射治療市場價值約為 70 億美元，預計 2024 年至 2032 年複合年成長率為 5.7%。這種治療通常使用 X光、伽馬射線或帶電粒子，重點是破壞癌細胞的 DNA，阻礙其生長和分裂。遞送方法包括外部機器，如直線加速器（外束放射治療）或將放射性材料內部放置在靠近癌細胞的地方（近距離放射治療）。

先進技術，特別是人工智慧（AI）和機器學習的融合，正在提高治療計劃的精確度和個人化程度。影像導引放射治療 (IGRT) 和調強放射治療 (IMRT) 等技術可最大限度地減少對健康組織的傷害，從而顯著轉向精確腫瘤靶向。由於其精確的劑量分佈，質子治療也越來越受到青睞，特別是對於兒科癌症和鄰近關鍵結構的腫瘤。大分割放射治療可以在較少的療程中提供更高的劑量，因其成本效益和便利性而進一步受到歡迎。

整個產業分為類型、應用、最終用途和地區。

市場將放射治療分為體外放射治療、體內放射治療和全身放射治療。外照射段又分為調強放射治療、影像導引放射治療、質子治療等方法。外照射部分引領市場，到 2023 年產生 46 億美元的收入。

從應用角度來看，市場涵蓋肺癌、攝護腺癌、乳癌、子宮頸癌、頭頸癌等。到了2023 年，乳癌領域的估值將達到20 億美元。顯著進步。

預測顯示，到 2032 年，北美放射治療市場將達到 41 億美元，其中美國領先，到 2023 年收入將達到 24 億美元。加速器，確保患者得到精準且有效率的治療。此外，公共和私營部門對研發的大量投資正在推動放射治療技術和設備的創新，最終帶來新的療法和改善的治療效果。

目錄

第 1 章：方法與範圍

第 2 章：執行摘要

第 3 章：產業洞察

• 產業生態系統分析
• 產業影響力
  • 成長動力
    • 放射治療技術進步
    • 全球癌症病例數不斷增加
    • 大眾對癌症治療的認知不斷提高
    • 增加醫療基礎建設和研發投資
  • 產業陷阱與挑戰
    • 發展中和低度開發地區缺乏技術精湛、經驗豐富的醫療保健專業人員
• 成長潛力分析
• 未來市場趨勢
• 監管環境
• 技術景觀
• 波特的分析
• PESTEL分析

第 4 章：競爭格局

• 介紹
• 公司市佔率分析
• 公司矩陣分析
• 主要市場參與者的競爭分析
• 競爭定位矩陣
• 戰略儀表板

第 5 章：市場估計與預測：按類型，2021 - 2032

• 主要趨勢
• 外束放射治療
  • 調強放射治療 (IMRT)
  • 影像導引放射治療 (IGRT)
  • 質子治療
  • 其他外部放射治療
• 內部放射治療
• 全身放射治療

第 6 章：市場估計與預測：按應用分類，2021 - 2032

• 主要趨勢
• 肺癌
• 攝護腺癌
• 乳癌
• 子宮頸癌
• 頭頸癌
• 其他應用

第 7 章：市場估計與預測：按最終用途，2021 - 2032 年

• 主要趨勢
• 醫院
• 放射治療中心及門診手術中心
• 癌症研究機構

第 8 章：市場估計與預測：按地區，2021 - 2032

• 主要趨勢
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 法國
  • 西班牙
  • 義大利
  • 歐洲其他地區
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 澳洲
  • 亞太地區其他地區
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 拉丁美洲其他地區
• 中東和非洲
  • 南非
  • 沙烏地阿拉伯
  • 中東和非洲其他地區

第 9 章：公司簡介

• Accuray Incorporated
• Brainlab AG
• Curium
• Canon Medical Systems Corporation
• Elekta AB
• Hitachi High-Tech Corporation
• IBA Radiopharma Solutions
• Isoray Inc.
• Mevion Medical Systems
• Mitsubishi Electric Corporation
• Nordion, Inc.
• NTP Radioisotopes SOC Ltd.
• RefleXion
• Toshiba Energy Systems and Solutions Corporation
• Varian Medical Systems, Inc.

The Global Radiotherapy Market was valued at approximately USD 7 billion in 2023 and is projected to grow at a CAGR of 5.7% from 2024 to 2032. Radiotherapy employs high doses of radiation to eradicate cancer cells and reduce tumor size. The treatment, typically using X-rays, gamma rays, or charged particles, focuses on damaging the DNA of cancer cells, hindering their growth and division. Delivery methods include external machines like linear accelerators (external beam radiotherapy) or internal placement of radioactive materials close to cancer cells (brachytherapy).

Integration of advanced technologies, especially artificial intelligence (AI) and machine learning, is refining the precision and personalization of treatment plans. There is a pronounced shift towards precise tumor targeting, with techniques like image-guided radiotherapy (IGRT) and intensity-modulated radiotherapy (IMRT) minimizing harm to healthy tissues. Proton therapy is also increasingly preferred, particularly for pediatric cancers and tumors adjacent to critical structures, due to its precise dose distribution. Hypofractionated radiotherapy, delivering higher doses over fewer sessions, is further gaining popularity for its cost-effectiveness and convenience.

The overall industry is divided into type, application, end use , and region.

The market categorizes types into external beam radiation therapy, internal radiation therapy, and systemic radiation therapy. The external beam segment further divides into intensity-modulated radiation therapy, image-guided radiation therapy, proton therapy, and other methods. The external beam segment led the market, generating a revenue of USD 4.6 billion in 2023. Advancements in imaging and delivery systems have bolstered the precision and efficacy of external beam radiation therapy (EBRT) for enabling targeted tumor treatment while safeguarding surrounding healthy tissues.

Application-wise, the market covers lung, prostate, breast, cervical, head & neck cancers, among others. The breast cancer segment led with a valuation of USD 2 billion in 2023. Techniques like three-dimensional conformal radiotherapy (3D-CRT) and intensity-modulated radiation therapy (IMRT) have seen significant advancements for enhancing treatment precision, effectiveness, and patient outcomes.

Forecasts suggest that the North American radiotherapy market will hit USD 4.1 billion by 2032, with the U.S. leading at a revenue of USD 2.4 billion in 2023. North America robust healthcare infrastructure supports the adoption of cutting-edge medical technologies, such as proton therapy and advanced linear accelerators, ensuring patients receive precise and efficient treatments. Moreover, substantial investments in research and development from both public and private sectors are driving innovation in radiotherapy techniques and equipment, culminating in novel therapies and improved treatment outcomes.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Technological advancement in radiotherapy
    • 3.2.1.2 Increasing number of cancer cases globally
    • 3.2.1.3 Growing public awareness related to cancer therapy
    • 3.2.1.4 Increasing healthcare infrastructure and R and D investments
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 Lack of skilled and experienced healthcare professionals in developing and underdeveloped regions
• 3.3 Growth potential analysis
• 3.4 Future market trends
• 3.5 Regulatory landscape
• 3.6 Technological landscape
• 3.7 Porter's analysis
• 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Type, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 External beam radiation therapy
  • 5.2.1 Intensity-modulated radiation therapy (IMRT)
  • 5.2.2 Image-guided radiation therapy (IGRT)
  • 5.2.3 Proton therapy
  • 5.2.4 Other external radiation therapies
• 5.3 Internal radiation therapy
• 5.4 Systemic radiation therapy

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Lung cancer
• 6.3 Prostate cancer
• 6.4 Breast cancer
• 6.5 Cervical cancer
• 6.6 Head and neck cancer
• 6.7 Other applications

Chapter 7 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Hospitals
• 7.3 Radiotherapy centers and ambulatory surgery centers
• 7.4 Cancer research institutes

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Rest of Latin America
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 Rest of Middle East and Africa

Chapter 9 Company Profiles

• 9.1 Accuray Incorporated
• 9.2 Brainlab AG
• 9.3 Curium
• 9.4 Canon Medical Systems Corporation
• 9.5 Elekta AB
• 9.6 Hitachi High-Tech Corporation
• 9.7 IBA Radiopharma Solutions
• 9.8 Isoray Inc.
• 9.9 Mevion Medical Systems
• 9.10 Mitsubishi Electric Corporation
• 9.11 Nordion, Inc.
• 9.12 NTP Radioisotopes SOC Ltd.
• 9.13 RefleXion
• 9.14 Toshiba Energy Systems and Solutions Corporation
• 9.15 Varian Medical Systems, Inc.